CellSeed Inc
TSE:7776
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bceg Environmental Remediation Co Ltd
SZSE:300958
|
CN |
|
AddLife AB
STO:ALIF B
|
SE |
CellSeed Inc
Total Assets
CellSeed Inc
Total Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
CellSeed Inc
TSE:7776
|
Total Assets
¥1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-4%
|
|
|
SanBio Co Ltd
TSE:4592
|
Total Assets
¥2.4B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-12%
|
|
|
GNI Group Ltd
TSE:2160
|
Total Assets
¥83.8B
|
CAGR 3-Years
35%
|
CAGR 5-Years
29%
|
CAGR 10-Years
29%
|
|
|
PeptiDream Inc
TSE:4587
|
Total Assets
¥77B
|
CAGR 3-Years
6%
|
CAGR 5-Years
24%
|
CAGR 10-Years
26%
|
|
|
Takara Bio Inc
TSE:4974
|
Total Assets
¥130.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
O
|
Oncolys Biopharma Inc
TSE:4588
|
Total Assets
¥4.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
10%
|
CAGR 10-Years
1%
|
|
CellSeed Inc
Glance View
CellSeed Inc. develops regenerative medicine products. The company is headquartered in Koto-Ku, Tokyo-To and currently employs 44 full-time employees. The company went IPO on 2010-03-16. The firm operates in two business segments. The Regenerative Medical Support segment is engaged in the research, development, manufacture and sale of temperature-responsive cell incubators. The Cell Sheet Regeneration Medical segment is involved in the research and development of cell sheet regenerative medical products.
See Also
What is CellSeed Inc's Total Assets?
Total Assets
1.7B
JPY
Based on the financial report for Dec 31, 2025, CellSeed Inc's Total Assets amounts to 1.7B JPY.
What is CellSeed Inc's Total Assets growth rate?
Total Assets CAGR 10Y
-4%
Over the last year, the Total Assets growth was -32%. The average annual Total Assets growth rates for CellSeed Inc have been 2% over the past three years , -2% over the past five years , and -4% over the past ten years .
